-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Globally, 463 million people had diabetes in 2019, and this number is expected to reach 578 million by 2030 and 700 million
The American Diabetes Association recommends lifestyle changes as the first step
Metformin and sulfonylureas are the most commonly used combination therapies
The Current Standard of Care of the American Diabetes Association recommends that 8.
The researchers conducted a comparative cross-sectional study
Of all the participants selected, 50.
Two-factor and multivariate Logistic regression analysis of factors associated with target levels of glycosylated hemoglobin in patients with diabetes mellitus
The risk of combined cardiovascular outcomes was higher in the metformin-insulin group (40.
In conclusion, comparative studies found that patients treated with metformin-sulfonylurea had a higher rate of target HbA1c levels and fewer
References: 1.
2.